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Abstract: Red meat is a risk factor for colorectal cancer (CRC). We wanted to evaluate 
whether a functional polymorphism in the HMOX1 gene encoding heme oxygenase 
modifies risk of CRC or interacts with diet or lifestyle factors because this would identify 
heme or heme iron as a risk factor of CRC. The HMOX1 A-413T (rs2071746) was 
assessed in relation to risk of colorectal cancer (CRC) and interactions with diet (red meat, 
fish, fiber, cereals, fruit and vegetables) and lifestyle (use of non-steroidal anti-inflammatory 
drug and smoking status) were assessed in a case-cohort study of 928 CRC cases and  
a comparison group of 1726 randomly selected participants from a prospective study of 
57,053 persons. No association between HMOX1 A-413T and CRC risk was found (TT vs. 
AA + TA; IRR = 1.15, 95% CI: 0.98–1.36, p = 0.10 for the adjusted estimate). No 
interactions were found between diet or lifestyle and HMOX1 A-413T. HMOX1 A-413T 
was not associated with CRC risk and no interactions with diet or lifestyle were identified 
in this large, prospective cohort with high meat intake. The results reproduced the previous 
findings from the same cohort and did not support a link between heme or heme iron and 
colorectal cancer. These results should be sought and replicated in other well-characterized 
cohorts with high meat intake.  
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1. Introduction 
Heme oxygenase (HO-1, encoded by HMOX1) is the inducible, rate-limiting enzyme converting 
heme to iron, carbon monoxide (CO) and biliverdin which is subsequently converted into bilirubin. 
HO-1 activity reduces cellular oxidative stress by removing the pro-oxidant heme and at the same  
time produces pro-inflammatory iron. Thus, HO-1 activity may help discriminate the underlying 
mechanisms involved in meat-related colorectal cancer (CRC) carcinogenesis. The HMOX1 A-413T 
and a microsatellite GT-dinucleotide repeat (GT)n polymorphisms are in strong linkage and haplotype 
analyses indicated that the HMOX1 A-413T genotype was likely to be the biologically functional 
polymorphism by modifying the promoter activity [1]. HMOX1 polymorphisms have been found to be 
associated with various diseases and interactions with diet has been suggested [2]. We have previously 
evaluated the HMOX1 A-413T polymorphism in a prospective Danish study of 383 cases of CRC and 
a sub-cohort of 763 participants [3]. We now extended this study in a larger cohort with power  
to assess gene-environment interaction. The aim of the present study was to evaluate whether the 
HMOX1 polymorphism modifies risk of CRC or interacts with diet or lifestyle factors in a larger 
updated study from the same cohort because this would identify heme or heme iron as risk factors for CRC. 
2. Results 
Baseline characteristics of the study participants are shown in Table 1. Median intake of fiber was 
statistically significantly lower and median intake of alcohol was statistically higher among cases 
compared to members of the sub-cohort. Also, a significantly lower proportion of the cases were past 
or current users of hormone replacement therapy compared to the members of the subcohort. The 
genotype distribution of the polymorphisms in the comparison group did not deviate from Hardy-Weinberg 
equilibrium (results not shown). The variant allele frequency in the sub-cohort was 0.41. 
Table 1. Baseline characteristics of the study participants by selected demographic and 
established colorectal cancer risk factors. 
Variable 
Cases Subcohort 
IRR a (95% CI) 
n (%) Median (5%–95%) n (%) Median (55%–95%) 
Total 928 (100) - 1726 (100) - - 
Sex - - - - - 
Men 521 (56) - 922 (53) - - 
Women 407 (44) - 804 (47) - - 
Age at inclusion (years) - 58 (51–64) - 56 (50–64) 0.97 (0.95–0.99) 
BMI (kg/m2) - 26.3 (20.7–34.0) - 25.6 (20.5–32.9) 1.03 (1.00–1.07) d
Food intake (g/day) - - - - - 
Alcohol b - 15.0 (1.2–71.6) - 14.0 (1.1–65.3) 1.04 (1.01–1.07) e
Dietary fiber - 19.9 (10.6–32.7) - 20.6 (10.7–34.1) 0.88 (0.80–0.97) f
Red and processed meat - 113.0 (47.1–233.4) - 109.2 (41.7–236.1) 1.02 (0.99–1.05) g
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Table 1. Cont. 
Variable 
Cases Subcohort 
IRR a (95% CI)
n (%) Median (5%–95%) n (%) Median (55%–95%) 
Smoking status - - - - - 
Never 277 (30) - 571 (33) - 1.00 (ref.) 
Past 284 (31) - 508 (29) - 1.03 (0.87–1.22)
Current 367 (39) - 647 (37) - 1.08 (0.92–1.27)
NSAID use c - -   - - 
No 643 (69) - 1185 (69) - 1.00 (ref.) 
Yes 285 (31) - 541 (31)  1.00 (0.87–1.15)
HRT use among women - - - - - 
Never 250 (61) - 425 (53) - 1.00 (ref.) 
Past 50 (13) - 124 (15) - 0.68 (0.50–0.93)
Current 107 (26) - 255 (32) - 0.76 (0.61–0.96)
Values are expressed as medians (5th and 95th percentiles) or as fractions (%); a Incidence rate ratios (IRRs) 
for CRC-mutually adjusted; b Among current drinkers; c NSAID use is defined as ≥2 pills per month during 
one year; d Risk estimate per 2 kg/m2 increment of BMI; e Risk estimate for the increment of 10 g alcohol per 
day; f Risk estimate for the increment of 10 g dietary fibers per day; g Risk estimate for the increment of 25 g 
red and processed meat per day; BMI, Body mass index; NSAID, Non-steroidal anti-inflammatory drugs; 
HRT, Hormone replacement therapy; IRR, Incidence rate ratios; 95% CI, 95% confidence interval. 
As shown in Table 2 no association between HMOX1 A-413T and CRC risk was found (TA vs. AA; 
Incidence rate ratios (IRR) = 1.00% and 95% Confidence Interval (95% CI): 0.86–1.15, p = 0.94,  
TT vs. AA; incidence rate ratio (IRR) = 1.15, 95% CI: 0.95–1.38, p = 0.15, and TT vs. AA + TA;  
IRR = 1.15, 95% CI: 0.98–1.36, p = 0.10, respectively, for the fully adjusted estimates (Table 2). A 
potential recessive effect was found and therefore AA and AT carriers were grouped vs. TT carriers to 
maximize the statistical power. 
Table 2. Incidence rate ratios (IRR) for colorectal cancer in relation to HMOX1 A-413T (rs2071746). 
HMOX1 n cases (%) n sub-cohort (%) IRR a (95% CI) IRR b (95% CI) p-Value c
AA 310 (33) 587 (34) 1.00 (ref.) 1.00 (ref.) - 
TA 446 (40) 864 (50) 1.01 (0.87–1.16) 1.00 (0.86–1.15) 0.94 
TT 172 (19) 275 (16) 1.16 (0.97–1.40) 1.15 (0.95–1.38) 0.15 
TA + TT vs. AA 618 (67) 1139 (66) 1.04 (0.91–1.20) 1.03 (0.90–1.18) 0.64 
TT vs. AA + TA 172 (19) 275 (16) 1.16 (0.98–1.37) 1.15 (0.98–1.36) 0.10 
a Crude-adjusted for age and sex; b In addition, adjusted for smoking status, alcohol, HRT status (women 
only), BMI, use of NSAID, intake of red and processed meat, and dietary fiber; c p-value for the adjusted 
estimates. IRR, Incidence rate ratios. 
No interactions were found between diet and HMOX1 A-413T using the continuous scale (p-value 
for interaction (Pint); meat = 0.97, fish = 0.18, cereal = 0.58, fiber = 0.69, fruit = 0.57, vegetables = 0.14) 
(Table 3). This analysis describes the increased risk pr25 gram meat per day (Table 3). Similarly,  
no interactions with diet were found using the tertile analysis (Table 4). No interactions were found 
between life style and HMOX1 A-413T (use of non-steroid anti-inflammatory drug p = 0.11, smoking 
status p = 0.75) (TT vs. AA + TA; IRR = 1.15, 95% CI: 0.98–1.36, p = 0.10 for the adjusted estimate) 
(Tables 5 and 6). 
Int. J. Mol. Sci. 2015, 16 1378 
 
 
Table 3. Interaction between dietary factors and HMOX1 A-413T (rs2071746) in relation 
to colorectal cancer risk. 
HMOX1 IRR a (95% CI) IRR b (95% CI) p-Value c IRR a (95% CI) IRR b (95% CI) p-Value c 
 Red and processed meat Fish 
AA + TA  
TT 
1.02 (0.99–1.05) 
1.02 (0.96–1.09) 
1.02 (0.99–1.05) 
1.02 (0.96–1.09) 
0.97 
0.96 (0.90–1.03) 
0.85 (0.72–1.00) 
0.97 (0.91–1.04)  
0.86 (0.73–1.02) 
0.18 
 Dietary cereal Dietary fiber 
AA + TA  
TT 
0.95 (0.90–1.00) 
0.98 (0.89–1.09) 
1.01 (0.94–1.09) 
1.04 (0.93–1.17) 
0.58 
0.87 (0.79–0.97) 
0.84 (0.68–1.04) 
0.89 (0.80–0.99)  
0.85 (0.69–1.05) 
0.69 
 Fruit Vegetables 
AA + TA  
TT 
0.97 (0.95–1.00) 
0.96 (0.92–1.01) 
0.98 (0.96–1.01) 
0.97 (0.93–1.02) 
0.57 
1.00 (0.96–1.04) 
0.93 (0.85–1.02) 
1.04 (0.99–1.08)  
0.97 (0.88–1.06) 
0.14 
a Analysis adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, intake of red 
and processed meat, and dietary fiber; b p-value for interaction between polymorphisms and dietary factors 
for the adjusted estimates; c p-value for the adjusted estimates. Red and processed meat per 25 g/day, Fish per 
25 g/day, Dietary cereal per 50 g/day, Dietary fiber per 10 g/day, Fruit per 50 g/day, Vegetables per 50 g/day. 
IRR, Incidence rate ratios. 
Table 4. IRR for colorectal cancer for tertiles of intake of dietary factors for HMOX1  
A-413T (rs2071746). 
HMOX1 1. Tertile 2. Tertile 3. Tertile 1. Tertile 2. Tertile 3. Tertile p-Value b
n c n s n c n s n c n s IRR (95% CI) a IRR (95% CI) a IRR (95% CI) a 
Red and processed meat 
AA + TA 251 548 257 462 248 441 1.00 (ref.) 1.25 (1.05–1.50) 1.28 (1.06–1.56) 
0.33 
TT 57 98 55 101 60 76 1.32 (0.98–1.78) 1.21 (0.92–1.61) 1.52 (1.13–2.04) 
Dietary cereal 
AA + TA 252 421 259 514 245 516 1.00 (ref.) 0.91 (0.76–1.10) 0.96 (0.76–1.21) 
0.51 
TT 61 97 52 91 59 87 1.07 (0.80–1.42) 0.99 (0.72-1.35) 1.27 (0.92–1.75) 
Fruit 
AA + TA 253 452 252 460 251 539 1.00 (ref.) 1.00 (0.83–1.20) 0.92 (0.74–1.13) 
0.93 
TT 60 90 59 89 53 96 1.20 (0.90–1.60) 1.13 (0.85–1.50) 1.02 (0.74–1.51) 
Fish 
AA + TA 257 528 255 417 244 506 1.00 (ref.) 1.12 (0.94–1.33) 0.93 (0.77-1.12) 
0.57 
TT 58 87 55 86 59 102 1.32 (0.98–1.78) 1.21 (0.91–1.61) 1.01 (0.76-1.34) 
Dietary fiber 
AA + TA 253 436 253 437 250 578 1.00 (ref.) 0.97 (0.82–1.16) 0.81 (0.68–0.97) 
0.37 
TT 60 98 59 75 53 102 1.05 (0.79–1.40) 1.33 (1.01–1.76) 0.89 (0.65–1.18) 
Vegetables 
AA + TA 249 439 252 501 255 511 1.00 (ref.) 1.06 (0.88–1.27) 1.12 (0.91–1.37) 
0.28 
TT 64 78 57 97 51 100 1.35 (1.02–1.80) 1.21 (0.90–1.62) 1.09 (0.79–1.49) 
a Analysis adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, intake of red 
and processed meat, and dietary fiber; b p-value for interaction between polymorphisms and dietary factors 
for the adjusted estimates; c cases, s sub-cohort. Tertiles of red and processed meat (<94.2266 g, 94.2266 g < 
and <139.266 g, >139.266 g), fish (<30.0189 g, 30.0189 g < and <48.0483 g, >48.0483 g), dietary fiber 
(<17.2846 g, 17.2846 g < and <22.4505 g, >22.4505 g), cereals (<152.202 g, 152.202 g < and <218.014 g,  
>218.014 g), fruit (<115.622 g, 115.622 g < and <224.174 g, >224.174 g), vegetables (<113.755 g, 113.755 g < 
and <197.250 g, >197.250 g). IRR, Incidence rate ratios. 
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Table 5. Interaction between NSAID use and HMOX1 A-413T (rs2071746) in relation to 
colorectal cancer risk. 
HMOX1 
NSAID Use n c/ n s NSAID Use IRR (95% CI)a NSAID Use IRR (95% CI) b 
p-Value c 
No Yes No Yes No Yes 
AA + TA  
TT 
539/1004  
104/181 
217/447  
68/94 
1.00 (ref.)  
1.05 (0.85–1.30) 
0.95 (0.81–1.11) 
1.32 (1.03–1.70) 
1.00 (ref.)  
1.04 (0.84–1.29) 
0.94 (0.80–1.10) 
1.30 (1.01–1.66) 
0.11 
a Crude-adjusted for age and sex; b In addition, adjusted for smoking status, alcohol, HRT status (women 
only), BMI, intake of red and processed meat, and dietary fiber; c p-value for interaction for the adjusted 
estimates; c cases, s sub-cohort. IRR, Incidence rate ratios. 
Table 6. Interaction between smoking status and HMOX1 A-413T (rs2071746) in relation 
to risk of colorectal cancer 
HMOX1 
Never  Past  Current Never  Past  Current  Never  Past  Current  
p-Value c 
n c/ n s n c/ n s n c/ n s 
IRR  
(95% CI) a 
IRR  
(95% CI) a
IRR  
(95% CI) a
IRR  
(95% CI) b
IRR  
(95% CI) b 
IRR  
(95% CI) b 
AA + TA 228/484 232/416 296/551 1.00 (ref.) 
1.07  
(0.89–1.28)
1.12  
(0.94–1.33)
1.00 (ref.) 
1.06  
(0.88–1.27) 
1.08  
(0.90–1.28) 
0.75 
TT 49/87 52/92 71/96 
1.24  
(0.90–1.69) 
1.11  
(0.83–1.50)
1.34  
(1.02–1.75)
1.20  
(0.88–1.64)
1.10  
(0.82–1.48) 
1.30  
(0.98–1.71) 
a Crude-adjusted for age and sex; b In addition, adjusted for alcohol, HRT status (women only), BMI, use of 
NSAID, intake of red and processed meat, and dietary fiber; c p-value for interaction for adjusted risk 
estimates; c cases, s sub-cohort. IRR, Incidence rate ratios. 
3. Discussion 
In the present candidate gene study, we extended our previous study of HMOX1 A-413T 
polymorphism in relation to diet, lifestyle and colorectal carcinogenesis in a study group of 383 CRC 
cases and 763 members of the comparison group to a larger cohort encompassing 928 number of  
cases and 1726 members of the comparison group and included more dietary factors. We found no 
association between HMOX1 A-413T and CRC risk and no interactions between diet and lifestyle and 
HMOX1 A-413T. Although no statistically significant interactions were found, we found that meat 
intake was associated with increased risk of CRC among carriers of both genotypes. Also, fiber intake 
was associated with lowered risk of CRC among carriers of both genotypes. We thus reproduced the 
previous finding that the studied HMOX1 polymorphism was not associated with risk of CRC [3].  
Our analyses suggest that genetically determined variation in heme oxygenase activity does not modify 
risk of CRC. Furthermore, we observed no interaction with meat intake. Thus, the results not support 
that intake of heme or heme iron from meat is linked to CRC. The investigated HMOX1 A-413T 
polymorphism was selected based on the role of the gene product in heme metabolism and the 
functional effect of the polymorphism. Of the two strongly linked HMOX1 promoter polymorphisms, 
the (GT)n repeats and the A-413T, the A-413T genotype was most likely responsible for the effect on 
the promoter activity [1]. Accordingly, this polymorphism has been found to be associated with 
various diseases [1,4,5]. To the best of our knowledge, apart from our previous analysis, no other large 
studies of heme oxygenase in relation to CRC have been performed to date [3]. 
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The study design has several strengths. The study design used in this study is well suited for 
analyzing interactions between genes and meat intake due to the collection of dietary and life style 
factors before diagnosis, the cases and controls being drawn from the same population, the large 
sample size and the relatively high meat intake [3,6–11] which may contribute to differential 
association pattern among populations with high and low meat intakes [12]. Study limitation includes 
limited power for detecting interactions. This study has more than 92% to detect a dominant effect of 
1.4 had it been there [13]. The average meat intake among controls was 109 g/day in the present study 
group, which is associated with a 10% increased risk of CRC. The present study has approximately 
80% chance of detecting a 3-fold difference in effect of meat intake with a primary effect of meat 
intake of 0.1 and an allele frequency of 0.41 [14]. Intake of meat may be associated with other CRC 
risk factors such as low fiber intake. However, we have adjusted for known risk factors in this cohort 
to minimize potential confounding. 
4. Experimental Section  
4.1. Studied Subjects 
The Diet, Cancer and Health Study is an ongoing Danish cohort study designed to investigate the 
relation between diet, lifestyle and cancer risk [15]. The cohort consists of 57,053 persons, recruited 
between December 1993 and May 1997. All the subjects were born in Denmark, and the individuals 
were 50 to 64 years of age and had no previous cancers at study entry. Blood samples and 
questionnaire data on diet and lifestyle were collected at study entry.  
4.2. Follow-Up and Endpoints  
Follow-up was based on population-based cancer registries. Between 1994 and 31 December 2009, 
970 CRC cases were diagnosed. A sub-cohort of 1897 persons was randomly selected within the 
cohort. Of these, 213 with missing genotype data were excluded. All information on genotypes and 
diet and lifestyle factors was available for 928 CRC cases and 1726 sub-cohort members.  
4.3. Dietary and Lifestyle Questionnaire 
Information on diet, lifestyle, weight, height, medical treatment, environmental exposures, and other 
socio-economic factors were collected at enrolment using questionnaires and interviews. In the  
food-frequency questionnaire, diet consumption was assessed in 12 categories of predefined responses, 
ranking from “never” to “eight times or more per day”. The daily intake was then calculated by using 
FoodCalc [15]. The study has been described in details elsewhere [3,6–11,15–19]. 
Smoking status was classified as never, past or current. Persons smoking at least 1 cigarette daily 
during the last year were classified as smokers. 
The lifestyle questionnaire included information on the frequency regarding of use of “Aspirin”, 
“Paracetamol”, “Ibuprofen”, or “Other pain relievers”. Based on all records, we classified study 
subjects according to use of “any NSAID” (≥2 pills per month during one year) at baseline. 
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4.4. Genotyping 
Buffy coat preparations were stored at minus 150 °C until use. DNA was extracted as described [20]. 
HMOX1 A-413T (rs2071746) was genotyped by KBioscience (KBioscience, Hoddesdon, UK) by 
PCR-based KASP™ genotyping assay (Available online: http://www.lgcgenomics.com/). To confirm 
reproducibility, genotyping was repeated for 10% of the samples yielding 100% identity. Laboratory 
staff was blinded for the status of the samples. 
4.5. Statistical Analysis 
Deviation from Hardy-Weinberg equilibrium was assessed using a Chi square test. 
Incidence rate ratios (IRR) and 95% Confidence Interval (95% CI) were calculated according to the 
principles for analysis of case-cohort studies using an un-weighted approach [21]. Age was used as the 
time scale in the Cox regression models. Tests and confidence intervals were based on Wald’s tests 
using the robust estimate of the variance-covariance matrix for the regression parameters in the Cox 
regression models [22] as previously described test [3,6–11,15–19]. 
All models were adjusted for baseline values of suspected risk factors for colorectal cancer such as 
body mass index (BMI) (kg/m2, continuous), NSAID (yes/no), use of hormone replacement therapy 
(HRT) (never/past/current, among women), smoking status (never/past/current), intake of dietary fiber 
(g/day, continuous), and red meat and processed meat (g/day, continuous). Cereals, fiber, fruit and 
vegetables were also entered linearly. All analyses were stratified by gender, so that the basic 
(underlying) hazards were gender specific. IRR was calculated separately for heterozygous and 
homozygous variant allele carriers. Since recessive effects were observed a recessive mode was used 
in the subsequent analyses. 
We investigated possible interactions between the polymorphism and intake of meat, dietary fiber, 
cereals, fish, fruit, vegetables, smoking status and use of non-steroid anti-inflammatory drug (NSAID) 
using the likelihood ratio test [3,6–11] 
In another set of interaction analyses between the polymorphism and the dietary intake subdivided 
in tertiles, dietary intake was entered as a categorical variable. Tertile cut-points were based on the 
empirical distribution among cases. The possible interactions were investigated using the likelihood 
ratio test. 
The procedure PHREG in SAS (release 9.3; SAS Institute, Cary, NC, USA) was used for the 
statistical analyses. A p < 0.05 was considered to be significant. 
The power to detect a dominant effect with an odds ratio of 1.5 and 1.4 was more than 98% and 
more than 92%, respectively [13]. 
The power to detect interaction was calculated. The average meat intake among controls was 109 g/day 
in the present study group, which is associated with a 10% increased risk of CRC. The power was 80% 
to detect a 3-fold difference in effect of meat intake with a primary effect of meat intake of 0.1 and  
an allele frequency of 0.41 [14]. 
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4.6. Ethics Statement 
All participants gave verbal and written informed consent. The Diet, Cancer and Health study was 
approved by the National Committee on Health Research Ethics (journal nr. (KF) 01-345/93) and the 
Danish Data Protection Agency. 
5. Conclusions 
The results reproduced our previous findings and do not support a link between heme or heme iron 
and colorectal cancer. The result should be evaluated in prospective cohorts with high meat intake. 
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